Technological advancements in insulin pens, pumps, and continuous glucose monitoring systems have greatly improved the convenience and effectiveness of rapid acting insulin. Current delivery devices ...

Please provide your email address to receive an email when new articles are posted on . Young children with type 1 diabetes had similar glycemic outcomes using fast-acting insulin aspart vs. standard ...

A team from Stanford University has developed an ultrafast-acting form of insulin that promises to work up to four times faster than current commercially available formulations. The novel drug has ...

Rise in availability of continuous glucose monitoring and surge in investments in R&D for human recombinant insulin drive the growth of the global rapid acting insulin market. PORTLAND, Ore., April 22 ...

The FDA on Monday approved fast-acting insulin aspart 100 U/mL as a mealtime insulin for children with diabetes, according to a press release from Novo Nordisk. Fast-acting insulin aspart (Fiasp) is ...

The US Food and Drug Administration has approved rapid-acting insulin lispro-aabc injection 100 and 200 units/mL (Lyumjev, Eli Lilly) for the treatment of adults with type 1 and type 2 diabetes. The ...

Insulin has proven an invaluable, life-saving hormone since the first diabetes sufferers were injected with it in the 1920s, but that doesn’t mean there isn’t room for improvement. Scientists at the ...

INDIANAPOLIS, Jan. 31, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has ...

SAN ANTONIO — For diabetics, controlling blood sugar is a matter of life and death. But a more obscure delivery method of inhaled insulin in starting to catch on. "I've grown up with it since I was 9 ...

An international research team led by scientists at University of Utah Health, Stanford University, and University of Copenhagen has developed a new form of fast-acting injectable insulin based on ...